Otsuka Pharmaceutical Co., Ltd. et al v. Aurobindo Pharma Ltd. et al
| Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S |
| Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd. |
| 1:2020cv01581 |
| November 23, 2020 |
| US District Court for the District of Delaware |
| Leonard P Stark |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 14, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Pro Hac Vice Attorneys Denise Main, Erin M. Sommers, C. Collette Corser, Tyler B. Latcham for H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01287-LPS et al.(kmd) |
SO ORDERED, re (14 in 1:20-cv-01365-LPS, 8 in 1:20-cv-01287-LPS, 13 in 1:20-cv-01296-LPS, 9 in 1:20-cv-01599-LPS, 7 in 1:20-cv-01428-LPS, 12 in 1:20-cv-01423-LPS, 11 in 1:20-cv-01335-LPS, 10 in 1:20-cv-01295-LPS, 7 in 1:20-cv-01581-LPS, 7 in 1:20-cv-01502-LPS, 7 in 1:20-cv-01763-LPS, 10 in 1:20-cv-01297-LPS, 11 in 1:20-cv-01332-LPS, 13 in 1:20-cv-01531-LPS) MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Denise Main, Erin M. Sommers, C. Collette Corser and Tyler B. Latcham filed by Otsuka Pharmaceutical Co.,Ltd, Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 1/5/21. Associated Cases: 1:20-cv-01287-LPS et al. (ntl)
|
| Filing 7 MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Denise Main, Erin M. Sommers, C. Collette Corser and Tyler B. Latcham - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co.,Ltd, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S. (Mayo, Andrew) |
| Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| No Summons Issued. (mal) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H. Lundbeck A/S. (mal) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Otsuka Pharmaceutical Co., Ltd. filed by Otsuka Pharmaceutical Co., Ltd.. (mal) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US RE48,059. (mal) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/12/2020. Date of Expiration of Patent: 04/12/2026; pending Patent Term Extension request, when granted, extends to 12/23/2028.Thirty Month Stay Deadline: 1/10/2023. (mal) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT - filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3350143.) - filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. (Attachments: #1 Exhibit A-B, #2 Civil Cover Sheet)(mal) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
